glp 1 risks long term GLP-1 has changed the conversation around weight loss—but it's important to understand what it can and cannot do. It's not the right choice for everyone, and it's not a replacement for healthy GLP-1 medications like Ozempic are

In clinical studies, higher levels of circulating long- and medium-chain acylcarnitines showed mixed results in patients with Alzheimers disease [24, 25] whereas clinical trials of patients with Parkinsons disease have consistently shown that circulating levels of long-chain acylcarnitines are decreased [26,27,28]

GLP-1-H24-4 (Phase Ib) Results GLP-1-H24-4 Trial Design GLP-1-H24-4 was conducted with 24-25 overweight, obese, pre- or type 2 diabetic patients in each of the five study arms (n=126), of which 4 arms evaluated various DehydraTECH formulations with the 5th being the Study control arm

L-theanine prevent quinolinic acid induced motor deficit and striatal neurotoxicity: reduction in oxido-nitrosative stress and restoration of striatal neurotransmitters level

The Role of Glutathione in the Body Detoxification : Glutathione binds to harmful substances, enabling their elimination from the body through urine or bile